CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 259 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $754,917 | -66.7% | 64,578 | -47.0% | 0.00% | -83.3% |
| Q4 2022 | $2,266,838 | +163.6% | 121,873 | -0.6% | 0.01% | +100.0% |
| Q2 2022 | $860,000 | -32.5% | 122,638 | -20.2% | 0.01% | -45.5% |
| Q1 2022 | $1,274,000 | +5.6% | 153,709 | -13.8% | 0.01% | +22.2% |
| Q4 2021 | $1,207,000 | +169.4% | 178,320 | +111.0% | 0.01% | +50.0% |
| Q3 2021 | $448,000 | +75.7% | 84,502 | +90.9% | 0.01% | +100.0% |
| Q2 2021 | $255,000 | +94.7% | 44,264 | +30.1% | 0.00% | -40.0% |
| Q1 2020 | $131,000 | – | 34,024 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 213,609 | $1,446,000 | 2.75% |
| GABLES CAPITAL MANAGEMENT INC. | 449,164 | $3,041,000 | 1.81% |
| Prairiewood Capital, LLC | 261,403 | $1,770,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 9,572,000 | $64,802,000 | 1.06% |
| Quantedge Capital Pte Ltd | 360,100 | $2,438,000 | 1.03% |
| SummerHaven Investment Management, LLC | 151,384 | $1,025,000 | 0.55% |
| GLOBEFLEX CAPITAL L P | 609,030 | $4,124,000 | 0.42% |
| EAM Global Investors LLC | 347,899 | $2,355,000 | 0.42% |
| Lanham O'Dell & Company, Inc. | 50,000 | $339,000 | 0.27% |
| EAM Investors, LLC | 239,071 | $1,619,000 | 0.27% |